Icon (FRA:IJF) Valuation Rank


FRA:IJF Icon PLC FRA:IJF
88 GF Score
Price €149.55
GF Value €199.59
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Icon Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Icon Valuation Rank Related Terms

FRA:IJF
88GF Score
Icon PLC FRA:IJF
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Icon (FRA:IJF) Overvalued in 2026?

Based on GuruFocus' analysis, Icon stock appears to be undervalued. The current stock price of €149.55 is trading 25.1% below its estimated GF Value™ of €199.59. GuruFocus considers Icon to be Modestly Undervalued.

Key valuation signals for FRA:IJF:

  • Valuation Rank:
  • GF Value™: €199.59 vs. price of €149.55 (25.1% below fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the FRA:IJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icon Business Description

Address South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
88GF Score

Get the complete analysis for FRA:IJF

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€149.55
Price
€199.59
GF Value